Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation

Immunological Investigations
Ying TianY Wang

Abstract

Graft-versus-host disease is a major complication of allogeneic hematopoietic stem cells transplantation, leading to serious morbidity and mortality. Mesenchymal stem cells(MSC)from bone marrow cause immunoregulation in vitro and in vivo. They also have the potential to protect from lethal GVHD after both autologous and allogeneic Hematopoietic Stem Cells Transplantation (HSCT). In this study, we investigated the mechanisms responsible for GVHD in the allo-HSCT co-transplantation with MSC condition. The model of acute GVHD in Rats was established using allogeneic HSC with donor-derived T cells transplantation, with or without additional donor-derived MSC co-transplantation. The degrees of GVHD were compared, the differentiation of CD4+, CD8+, Th1/Th2 and CD4+CD25+ T cells in vivo were assessed by flow cytometry and RT-PCR analyses. We found that MSC inhibited lethal GVHD after allo-HSCT. The value of CD8+ and CD4+ T cells and the ratio of Th1/Th2 T cell subsets decreased, at the same time the proportion of CD4+CD25+ T cells increased both in spleen lymphocytes and thymocytes in vivo after allo-HSCT with MSC co-transplantation compared with conventional allo-HSCT. Our results strongly suggested that BM-derived MSC has the functi...Continue Reading

Citations

Feb 4, 2010·Human Gene Therapy·Maria Teresa Lupo-StanghelliniChiara Bonini
May 26, 2010·Experimental & Molecular Medicine·Jeong Sup SongSung Hak Park
May 25, 2011·World Journal of Stem Cells·Farbod RastegarTong-Chuan He
Jul 3, 2013·Cell Transplantation·Catarina Oliveira MirandaMónica Mendes Sousa
Oct 16, 2008·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Piotr TrzonkowskiAndrzej Myśliwski
Jul 25, 2009·Pediatric Diabetes·Catarina Limbert, Jochen Seufert
Jun 18, 2010·Cellular and Molecular Life Sciences : CMLS·Stephan FrickeUlrich Sack
Dec 2, 2010·Pediatric Diabetes·Paul Benitez-Aguirre, David M Maahs
Apr 22, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Haojie ZhuTing Yang
Dec 21, 2011·International Journal of Hematology·Lei HaoZhongmin Zou
Jun 30, 2016·Health Physics·Juliann G Kiang
Jan 5, 2016·Stem Cells·Jiao-Le YuGodfrey Chi-Fung Chan
Feb 9, 2011·Journal of Cellular Physiology·Cristina ManferdiniGina Lisignoli
Jan 19, 2016·Cell Biochemistry and Function·Dae Seong KimKeon Hee Yoo
Apr 15, 2009·Journal of Cellular Physiology·Gina LisignoliAntonino Neri
Jun 25, 2008·The Annals of Thoracic Surgery·Rony AtouiRay C J Chiu
Jun 4, 2013·Gastroenterology·Kyung Hee JungSoon-Sun Hong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.